Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Medical Genetics 2006;43:e16; doi:10.1136/jmg.2005.035006
Copyright © 2006 by the BMJ Publishing Group Ltd.

ELECTRONIC LETTER

Influence of glutathione-S-transferase (GSTM1, GSTP1, GSTT1) and cytochrome p450 (CYP1A1, CYP2D6) polymorphisms on numbers of basal cell carcinomas (BCCs) in families with the naevoid basal cell carcinoma syndrome

X (R) Yang, R M Pfeiffer, A M Goldstein

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, USA

Correspondence to:
Correspondence to:
Dr Xiaohong (Rose) Yang
Genetic Epidemiology Branch, DCEG, NCI, 6120 Executive Blvd., Rm 7014, Bethesda, MD 20852, USA; royang{at}mail.nih.gov

Background: The naevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant multisystem disorder with variable expression. NBCCS patients have variable susceptibility to development of basal cell carcinoma (BCC). Previous studies have shown that polymorphisms of some metabolic genes encoding the cytochrome p450 (CYP) and glutathione-S-transferase (GST) enzymes influenced the numbers of BCCs in sporadic BCC cases.

Objective: To determine whether allelic variants of these genes contribute to the variation in numbers of BCCs observed in NBCCS families.

Methods: Genotyping and analysis was carried out in 152 members (69 affected and 83 unaffected) of 13 families with NBCCS for seven polymorphisms in five metabolic genes including CYP1A1, CYP2D6, GSTM1, GSTP1, and GSTT1.

Results: GSTP1 Val105 and GSTP1 Val114 alleles were significantly associated with fewer BCC numbers (odds ratio (OR)105 = 0.55 (95% confidence interval, 0.35 to 0.88); OR114 = 0.20 (0.05 to 0.88)). The Val105 allele showed a dose dependent effect (ORIle/Val = 0.58 (0.34 to 0.88); ORVal/Val = 0.34 (0.14 to 0.78)). In addition, fewer jaw cysts were observed in carriers of the three p450 polymorphisms (CYP1A1m1, CYP1A1m2, and CYP2D6*4) (ORCYP1A1m1 = 0.27 (0.12 to 0.58); ORCYP1A1m2 = 0.25 (0.08 to 0.78); ORCYP2D6*4 = 0.33 (0.18 to 0.60)).

Conclusions: Genetic variants might contribute to the variation in numbers of BCCs and jaw cysts observed in NBCCS families.

Abbreviations: BCC, basal cell carcinoma; BPDE, benzo(a)pyrene diol epoxide; GEE, generalised estimating equations; GST, glutathione-S-transferase; NBCCS, naevoid basal cell carcinoma syndrome; PAH, polycyclic aromatic hydrocarbon

Keywords: glutathione-S-transferase; cytochrome p45; genetic polymorphism; naevoid basal cell carcinoma syndrome


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Moyer, A. M., Salavaggione, O. E., Wu, T.-Y., Moon, I., Eckloff, B. W., Hildebrandt, M. A.T., Schaid, D. J., Wieben, E. D., Weinshilboum, R. M. (2008). Glutathione S-Transferase P1: Gene Sequence Variation and Functional Genomic Studies. Cancer Res. 68: 4791-4801 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Genetics jobs

Genetics jobs